stockrowIntegra LifeSciences Holdings Corporation (IART) vs PROCEPT BioRobotics Corporation (PRCT)
- Integra LifeSciences Holdings Corporation IART 13.98 −0.99%
- PROCEPT BioRobotics Corporation PRCT 20.59 +1.58%
Integra LifeSciences Holdings Corporation and PROCEPT BioRobotics Corporation are both Medical Devices companies. Integra LifeSciences Holdings Corporation and PROCEPT BioRobotics Corporation are of similar size ($1.2B and $1.1B). PROCEPT BioRobotics Corporation has negative trailing earnings, so its P/E is not meaningful; Integra LifeSciences Holdings Corporation trades at 83.0×. PROCEPT BioRobotics Corporation grew revenue faster over the last twelve months: 17.5% against 0.84%. Integra LifeSciences Holdings Corporation has the higher net margin (0.79% vs −32.6%) and the higher return on invested capital (1.79% vs −45.6%). Across the 18 metrics below, Integra LifeSciences Holdings Corporation leads on 12 and PROCEPT BioRobotics Corporation on 6.
Valuation
Profitability
| Metric | IART | PRCT | Medical Devices median |
|---|---|---|---|
| Gross margin | 52.36% | 64.66% | 57.76% |
| Operating margin | 4.39% | (33.61%) | (15.07%) |
| Net margin | 0.79% | (32.60%) | (14.45%) |
| Free cash flow margin | 5.18% | (24.15%) | (3.88%) |
| Return on equity | 1.24% | (32.39%) | (10.35%) |
| Return on assets | 0.36% | (23.31%) | (17.26%) |
| Return on invested capital | 1.79% | (45.60%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack